サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1703398

冠動脈ポリマーエンドステント市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、地域別、競争別、2020-2030F

Coronary Artery Polymer Endostents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application By Region & Competition, 2020-2030F

出版日
ページ情報
英文 180 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

冠動脈ポリマーエンドステント市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、地域別、競争別、2020-2030F
出版日: 2025年04月11日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

冠動脈ポリマーエンドステントの世界市場規模は、2024年に48億2,000万米ドルとなり、2030年までの年間平均成長率（CAGR）は5.20%で、予測期間中は安定した成長が予測されています。

この市場は、ヘルスケア業界においてダイナミックかつ急速に発展しているセグメントであり、冠動脈疾患（CAD）の治療において重要な役割を果たしています。

市場概要
予測期間 2026-2030
市場規模：2024年 48億2,000万米ドル
市場規模：2030年 65億5,000万米ドル
CAGR：2025年～2030年 5.20%
急成長セグメント PLLA
最大市場 北米

心臓に血液を供給する動脈の狭窄を特徴とする冠動脈疾患は、世界的に死亡と身体障害の主な原因となっています。高分子エンドステントは、従来の冠動脈バイパス手術に代わる低侵襲の選択肢を提供する、画期的なソリューションとして登場しました。これらの先進医療機器-生体適合性ポリマーで作られた拡張可能な小型チューブ-は、閉塞または狭窄した冠動脈に挿入され、血流を回復・維持します。

不健康な食生活、座りがちな生活、世界の高齢化などのライフスタイル要因によってCADの有病率が増加していることが、市場拡大の主な要因となっています。ポリマー製エンドステントは、一般に血管形成術として知られる経皮的冠動脈形成術（PCI）を通じて導入されます。

技術革新はこの市場を形成し続けており、薬剤溶出能の向上、生体吸収性材料、デリバリー機構の強化などを備えた次世代ポリマー内留置剤の開発につながっています。これらの進歩は、再狭窄（血管の再狭窄）や血栓症（血の塊の形成）のリスクを低減すると同時に、組織の迅速な治癒と統合をサポートするように設計されています。さらに、心血管危険因子に対する意識の高まりと新興市場におけるヘルスケアインフラの強化が、この分野の世界的拡大に寄与しています。

主な市場促進要因

冠動脈疾患（CAD）の有病率の上昇

主な市場課題

規制上の障壁

主な市場動向

低侵襲手技の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の冠動脈ポリマーエンドステント市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別（PLGA、PLLA、PDLA、脱アミノ化チラミンポリカーボネートユーカテック）
    • 用途別（急性心筋梗塞、急性血管閉塞、その他）
    • 企業別（2024）
    • 地域別
  • 市場マップ

第6章 北米の冠動脈ポリマーエンドステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の冠動脈ポリマーエンドステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の冠動脈ポリマーエンドステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の冠動脈ポリマーエンドステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの冠動脈ポリマーエンドステント市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Eucatech AG
  • MicroPort Scientific Corporation
  • Rontis Medical
  • Meril Life Sciences
  • Alvimedica Medical Technologies
  • InSitu Technologies
  • Elixir Medical
  • SINOMED Inc
  • Amaranth Medical Inc
  • Amg International

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 16731

The Global Coronary Artery Polymer Endostents Market was valued at USD 4.82 billion in 2024 and is projected to experience stable growth over the forecast period, with a compound annual growth rate (CAGR) of 5.20% through 2030. This market represents a dynamic and rapidly evolving segment within the healthcare industry, playing a critical role in the treatment of coronary artery disease (CAD).

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.82 Billion
Market Size 2030USD 6.55 Billion
CAGR 2025-20305.20%
Fastest Growing SegmentPLLA
Largest MarketNorth America

Coronary artery disease, characterized by the narrowing of the arteries that supply blood to the heart, continues to be a leading cause of death and disability worldwide. Polymer endostents have emerged as a transformative solution, offering a minimally invasive alternative to conventional coronary artery bypass surgery. These advanced medical devices-small, expandable tubes made from biocompatible polymers-are inserted into blocked or narrowed coronary arteries to restore and maintain blood flow.

The increasing prevalence of CAD, driven by lifestyle factors such as unhealthy diets, sedentary behavior, and an aging global population, is a primary factor fueling market expansion. Polymer endostents are typically deployed through percutaneous coronary intervention (PCI), commonly known as angioplasty, a widely adopted procedure due to its efficiency and shorter recovery times compared to surgical approaches.

Technological innovations continue to shape this market, leading to the development of next-generation polymer endostents with improved drug-eluting capabilities, bioabsorbable materials, and enhanced delivery mechanisms. These advancements are designed to reduce the risks of restenosis (vessel re-narrowing) and thrombosis (blood clot formation) while supporting faster tissue healing and integration. Additionally, rising awareness of cardiovascular risk factors and the strengthening of healthcare infrastructure in emerging markets are contributing to the sector's global expansion.

Key Market Drivers

Rising Prevalence of Coronary Artery Disease (CAD)

The growing incidence of CAD is a major driver behind the expansion of the Coronary Artery Polymer Endostents Market. CAD is the foremost cause of mortality globally, responsible for an estimated 17.9 million deaths annually-approximately 85% of which are due to heart attacks and strokes. According to the World Health Organization (WHO), addressing risk factors such as hypertension, obesity, and diabetes is essential to reducing premature deaths and alleviating the global healthcare burden caused by cardiovascular diseases.

In 2022, the estimated number of active CAD cases reached 315 million worldwide, highlighting the scale of this public health challenge. Sedentary lifestyles, poor dietary habits, smoking, and a rising incidence of comorbid conditions have all contributed to this increase. Consequently, there is a growing demand for effective and minimally invasive treatment options like coronary artery polymer endostents.

These stents offer a less invasive solution compared to traditional bypass surgery, functioning as internal scaffolds to keep arteries open while also delivering drugs that help prevent complications such as restenosis and thrombosis. Their use translates into shorter hospital stays, quicker recovery times, and fewer post-operative complications.

As healthcare systems increasingly focus on cost-effective and efficient treatment methods, polymer endostents are gaining favor for their clinical effectiveness and economic viability. Their minimally invasive nature aligns with the healthcare industry's shift toward outpatient care and same-day discharge protocols. Furthermore, the aging population-more vulnerable to CAD-underscores the importance of expanding access to such advanced treatment solutions.

Key Market Challenges

Regulatory Barriers

Despite significant technological progress and the increasing importance of polymer endostents in CAD management, the market faces several regulatory challenges that may impede growth. The medical device approval landscape is complex and varies significantly across global regions. Regulatory authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national bodies impose distinct and often rigorous requirements for market access.

This lack of regulatory harmonization results in extended approval timelines and elevated development costs. Manufacturers must navigate a demanding approval process, which includes extensive preclinical and clinical testing, as well as comprehensive documentation. Although these requirements ensure patient safety and product efficacy, they also delay commercialization and inflate operational expenses.

Moreover, regional discrepancies in regulatory expectations compel manufacturers to tailor their submissions for individual markets, adding further complexity to global expansion efforts. This fragmented regulatory landscape remains a key obstacle to the broader adoption and availability of coronary artery polymer endostents.

Key Market Trends

Advancement of Minimally Invasive Procedures

The increasing adoption of minimally invasive procedures is significantly contributing to the growth of the Coronary Artery Polymer Endostents Market. These approaches have revolutionized the treatment paradigm for CAD, offering both patients and providers a less intrusive and more efficient alternative to traditional surgery.

Polymer endostents are central to these procedures, deployed through catheter-based techniques rather than open-heart surgery. This method minimizes physical trauma, leading to less pain, reduced blood loss, and faster recovery. Patients benefit from shorter hospital stays and a quicker return to daily activities, ultimately improving quality of life.

Clinically, minimally invasive techniques enhance procedural precision, allowing cardiologists to navigate complex vascular anatomies with greater ease and safety. These procedures also tend to have fewer complications and shorter durations, making them increasingly attractive in busy healthcare settings.

The trend toward minimally invasive interventions, combined with ongoing product innovation and improved patient outcomes, is expected to continue propelling the coronary artery polymer endostents market forward.

Key Market Players

  • Eucatech AG
  • MicroPort Scientific Corporation
  • Rontis Medical
  • Meril Life Sciences
  • Alvimedica Medical Technologies
  • InSitu Technologies
  • Elixir Medical
  • SINOMED Inc
  • Amaranth Medical Inc
  • Amg International

Report Scope:

In this report, the Global Coronary Artery Polymer Endostents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Coronary Artery Polymer Endostents Market, By Type:

  • PLGA
  • PLLA
  • PDLA
  • Deamination Tyramine Polycarbonateeucatech

Coronary Artery Polymer Endostents Market, By Application:

  • Acute Myocardial Infarction
  • Acute Vascular Blockage
  • Other

Coronary Artery Polymer Endostents Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Coronary Artery Polymer Endostents Market.

Available Customizations:

Global Coronary Artery Polymer Endostents market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Coronary Artery Polymer Endostents Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (PLGA, PLLA, PDLA, Deamination Tyramine Polycarbonateeucatech)
    • 5.2.2. By Application (Acute Myocardial Infarction, Acute Vascular Blockage, Other)
    • 5.2.3. By Company (2024)
    • 5.2.4. By Region
  • 5.3. Market Map

6. North America Coronary Artery Polymer Endostents Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Coronary Artery Polymer Endostents Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Coronary Artery Polymer Endostents Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Coronary Artery Polymer Endostents Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Coronary Artery Polymer Endostents Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Coronary Artery Polymer Endostents Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Coronary Artery Polymer Endostents Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Coronary Artery Polymer Endostents Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Coronary Artery Polymer Endostents Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Coronary Artery Polymer Endostents Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Coronary Artery Polymer Endostents Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Coronary Artery Polymer Endostents Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Coronary Artery Polymer Endostents Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Coronary Artery Polymer Endostents Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Coronary Artery Polymer Endostents Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Coronary Artery Polymer Endostents Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Coronary Artery Polymer Endostents Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Coronary Artery Polymer Endostents Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Coronary Artery Polymer Endostents Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Coronary Artery Polymer Endostents Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Coronary Artery Polymer Endostents Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Coronary Artery Polymer Endostents Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Coronary Artery Polymer Endostents Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Coronary Artery Polymer Endostents Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Eucatech AG
    • 15.1.1. Business Overview
    • 15.1.2. Product & Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Financials (If Listed)
    • 15.1.5. Key Personnel
    • 15.1.6. SWOT Analysis
  • 15.2. MicroPort Scientific Corporation
  • 15.3. Rontis Medical
  • 15.4. Meril Life Sciences
  • 15.5. Alvimedica Medical Technologies
  • 15.6. InSitu Technologies
  • 15.7. Elixir Medical
  • 15.8. SINOMED Inc
  • 15.9. Amaranth Medical Inc
  • 15.10. Amg International

16. Strategic Recommendations

17. About Us & Disclaimer